TP53 and neoplasm: The immunomodulatory effects also give hope for possible relevant synergistic effects with other tumor-active substances, such as paclitaxel [26,27], ifosfamide [27], p53 cancer vaccine [28], vinorelbine [29] and 5-fluorouracil (5-FU) [30].